1Broadway DC, Grierson I, O' Brien C, Hitchings RA. Adverse effects of topical antiglaucomatous medications, II : the outcome of filtration surgery [ J]. Arch Ophthalmol 1994 ; 112 : 1446-1454.
2Eleftheriadis H, Cheong M, Sandeman S. Corneal toxicity secondary to inadvertent use of benzalkontum chloride preserved viscoelastic material in cataract surgery[ J ]. Br J Oph thalmol 2002 ; 86 : 299-305.
4Herbst RA, Uter W,Pirker C,Findlay C. Allergic and nonallergic periorbital dermatitis:patch test results of the information network of the departments of dermatology during a 5-year period [ J ]. CODEDG (Contact Dermatitis )2004;51:13-19.
5Pisella PJ, Pouliquen P, Baudouin C. Prevalence of octtlar symptoms and signs with preserved and preservative free glaucoma medication [ J ]. Br J Oph t halmol 2002;86:418.
6Guenoun JM,Baudottin C,Rat P,Pauly A,Warnet JM,Brignole BF. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells[ J]. Invest Ophthalmol Vis Sci 2005 ;46(7) :2444-2450.
7Catherine PH,Debbasch B,Warnet JM,Baudouin C, Brignole F. In vitro effects of preservedand tmpreserved antiglaucoma drugson apoptotic marker expression by httman trabecttlar cells [ J]. Graefe Arch Clin Exp Ophthalmol 2003 ;241 : 1037-1043.
8Lee DA, Higginbotham EJ. glaucoma and its treatment[ J]. Am J Health Syst Pharrn 2005 ;62 (7) :691-699.
9Dong Y,Ishikawa H,Wu Y, Shtmizu K, Goseki T,Yoshitomi T. Effect and mechanism of betaxolol and timolol on vascular relaxation in isolated rabbit ciliary artery[J]. Jpn J Ophthalmol 2006 ;50:504-508.
10Woodward DF, Phelps RL, Krauss AH, Weber A, Short B, Chert J,et al. Bimatoprost: a novel antiglaueoma agent[J]. Cardiovasc Drug Rev 2004 ;22 ( 2 ) : 103-120.
